← Leaderboards
Howard Tranter
$12,180,851
Attributed
$12,180,851
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.4M · FY2017–19$10M$7.5M$5M$2.5M$0
'17
'18
'19
Funding mix
By agency
NIH$12,180,851 · 1
By mechanism
N01$12,180,851 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Anthrax Vaccines”
- Nadine Georges Rouphael · Emory University$10,156,675
- Evan J Anderson · Emory University$3,857,570
- Ronald T Aimes · Mapp Biopharmaceutical, Inc.$2,000,000
- Ramin M. Hakami · Integrated Biotherapeutics, Inc.$1,081,166
- David R Fooksman · Albert Einstein College Of Medicine, Inc$974,908
- Jason Mott · Battelle Centers/Pub Hlth Res & Evaluatn$512,126
Research focus
Anthrax VaccinesClinical ResearchCyclic GmpFormulationInvestigational DrugsNext GenerationProduct DevelopmentReagentStability TestingSupport ContractsTechnologyToxicologyVaccinesValidation
Grant awards (3)
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES$4,999,700
N01 · FY2019 · AI · contact PI
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES$768,782
N01 · FY2018 · AI · contact PI
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES$6,412,369
N01 · FY2017 · AI · contact PI